Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates

Ebola viruses cause hemorrhagic disease in humans and nonhuman primates with high fatality rates. These viruses pose a significant health concern worldwide due to the lack of approved therapeutics and vaccines as well as their potential misuse as bioterrorism agents. Although not licensed for human...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Marzi, Andrea, Engelmann, Flora, Feldmann, Friederike, Haberthur, Kristen, Shupert, W. Lesley, Brining, Douglas, Scott, Dana P., Geisbert, Thomas W., Kawaoka, Yoshihiro, Katze, Michael G., Feldmann, Heinz, Messaoudi, Ilhem
Formato: Artigo
Idioma:Inglês
Publicado: National Academy of Sciences 2013
Assuntos:
Biological Sciences
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3562844/
https://ncbi.nlm.nih.gov/pubmed/23319647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1209591110
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares